Sequenom (SQNM) - where do we go from here? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sequenom (SQNM) - where do we go from here?

SQNM 2.390

0.0%

Sep 8 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: dr_elis	4/26/2014 4:19:13 AM
	of 2

SQNM competitor Ariosa files for IPO: venturebeat.com Very risky, if SQNM prevails in the legal patent battle Ariosa goes belly up. The original legal win for Ariosa was highly controversial - SQNM has good chances to make their appeal a success. If the appeal fails basically no one in the NIPT space holds meaningful patents in the US rendering the market wide open for lots and lots of competition. In other words, while there are huge growth opportunities the competition will erode prices making an investment in NIPT companies fairly unattractive. On the patent dispute between SQNM and Ariosa: dilworthip.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext